Format

Send to

Choose Destination
Paediatr Child Health. 2018 Nov;23(7):462-472. doi: 10.1093/pch/pxy113. Epub 2018 Oct 24.

ADHD in children and youth: Part 2-Treatment.

[Article in English, French]

Author information

1
Canadian Paediatric Society, Mental Health and Developmental Disabilities Committee, Ottawa, Ontario.

Abstract

Attention-deficit hyperactivity disorder (ADHD) is a chronic neurodevelopmental disorder. Three position statements have been developed by the Canadian Paediatric Society, following systematic literature reviews. Statement objectives are to: 1) Summarize the current clinical evidence regarding ADHD,2) Establish a standard for ADHD care, and3) Assist Canadian clinicians in making well-informed, evidence-based decisions to enhance care of children and youth with this condition. Specific topics reviewed in Part 2, which focuses on treatment, include: evidence and context for a range of clinical approaches, combining behavioural and pharmacological interventions to address impairment more effectively, the role of parent and teacher (or other caregiver) training, the use of stimulant and nonstimulant medications, with effects and risks, and dosing and monitoring protocols. Treatment recommendations are based on current guidelines, evidence from the literature, and expert consensus.

KEYWORDS:

ADHD; Adverse effects; Combined interventions; Medication management

PMID:
30681665
PMCID:
PMC6199639
[Available on 2019-11-01]
DOI:
10.1093/pch/pxy113

Supplemental Content

Loading ...
Support Center